Commit To Purchase Melinta Therapeutics At $5, Earn 17.3% Annualized Using Options
June 21, 2018 at 12:03 PM EDT
Investors considering a purchase of Melinta Therapeutics Inc (MLNT) stock, but cautious about paying the going market price of $7.58/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2019 put at the $5 strike, which has a bid at the time of this writing of 50 cents..